Barrington Research Maintains Outperform on Imax, Maintains $25 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst James Goss maintains an Outperform rating on Imax (NYSE:IMAX) with a $25 price target.
July 26, 2024 | 1:49 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barrington Research analyst James Goss has reaffirmed an Outperform rating on Imax (NYSE:IMAX) and maintained a $25 price target.
The reaffirmation of an Outperform rating and a $25 price target by Barrington Research is a positive signal for investors, indicating confidence in the company's future performance. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100